Jonathan Ofer

746 total citations
9 papers, 100 citations indexed

About

Jonathan Ofer is a scholar working on Psychiatry and Mental health, Infectious Diseases and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jonathan Ofer has authored 9 papers receiving a total of 100 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Psychiatry and Mental health, 2 papers in Infectious Diseases and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jonathan Ofer's work include Epilepsy research and treatment (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and EEG and Brain-Computer Interfaces (2 papers). Jonathan Ofer is often cited by papers focused on Epilepsy research and treatment (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and EEG and Brain-Computer Interfaces (2 papers). Jonathan Ofer collaborates with scholars based in Israel, Canada and Italy. Jonathan Ofer's co-authors include Alon Friedman, Dan Z. Milikovsky, Federica Frigerio, Massimo Rizzi, Liron Sheintuch, Annamaria Vezzani, Lyna Kamintsky, Kristina Lippmann, Itai Weissberg and Ronel Veksler and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Stroke.

In The Last Decade

Jonathan Ofer

8 papers receiving 100 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Ofer Israel 4 39 39 34 17 15 9 100
Domenico Serino Italy 9 30 0.8× 76 1.9× 35 1.0× 61 3.6× 7 0.5× 22 192
José C. Ferreira Portugal 7 40 1.0× 75 1.9× 29 0.9× 45 2.6× 24 1.6× 9 271
Gabrielle Bouchard Germany 6 36 0.9× 17 0.4× 25 0.7× 14 0.8× 14 0.9× 12 130
Barbora Beňová Czechia 8 31 0.8× 73 1.9× 18 0.5× 23 1.4× 4 0.3× 17 160
B. Guo China 6 28 0.7× 27 0.7× 15 0.4× 13 0.8× 12 0.8× 18 86
Yuko Shimizu‐Motohashi Japan 6 29 0.7× 31 0.8× 16 0.5× 45 2.6× 3 0.2× 30 121
Anne Kinhult Ståhlbom Sweden 7 15 0.4× 33 0.8× 12 0.4× 38 2.2× 5 0.3× 10 135
Alfredo Rodríguez-Antigüedad Spain 9 12 0.3× 12 0.3× 28 0.8× 24 1.4× 8 0.5× 26 161
Liling Dong China 7 8 0.2× 38 1.0× 14 0.4× 21 1.2× 6 0.4× 34 146
Jun Mine Japan 5 6 0.2× 50 1.3× 36 1.1× 27 1.6× 5 0.3× 9 113

Countries citing papers authored by Jonathan Ofer

Since Specialization
Citations

This map shows the geographic impact of Jonathan Ofer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Ofer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Ofer more than expected).

Fields of papers citing papers by Jonathan Ofer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Ofer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Ofer. The network helps show where Jonathan Ofer may publish in the future.

Co-authorship network of co-authors of Jonathan Ofer

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Ofer. A scholar is included among the top collaborators of Jonathan Ofer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Ofer. Jonathan Ofer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Meirson, Tomer, Jonathan Ofer, Avital Bareket‐Samish, et al.. (2025). Reanalysis of Urothelial Cancer Chemoimmunotherapy Trials With Differential Censoring. JAMA Network Open. 8(1). e2455630–e2455630. 1 indexed citations
2.
Nobel, H., Jonathan Ofer, Dror Limon, et al.. (2025). Long-term impact of bevacizumab for the treatment of brain radiation necrosis. Journal of Neuro-Oncology. 173(2). 289–296.
3.
Ofer, Jonathan, et al.. (2024). Mortality and Hospitalization Risk in Solid Organ Transplant Patients and SARS-CoV-2-Omicron Variant. Transplantation. 109(2). e142–e143. 1 indexed citations
4.
Tannock, Ian F., Daniel A. Goldstein, Jonathan Ofer, Bishal Gyawali, & Tomer Meirson. (2023). Evaluating Trials of Adjuvant Therapy: Is There Benefit for People With Resected Renal Cancer?. Journal of Clinical Oncology. 41(15). 2713–2717. 10 indexed citations
5.
Ofer, Jonathan, et al.. (2023). Mortality and Hospitalization Risks in Patients With Cancer and the SARS-CoV-2 Omicron Variant. JAMA Oncology. 10(1). 137–137. 3 indexed citations
6.
Goldberg, Ilan, Oded Shor, Dan Z. Milikovsky, et al.. (2021). Paroxysmal slow wave events predict epilepsy following a first seizure. Epilepsia. 63(1). 190–198. 14 indexed citations
7.
Serlin, Yonatan, Jonathan Ofer, Ronel Veksler, et al.. (2019). Blood-Brain Barrier Leakage. Stroke. 50(5). 1266–1269. 21 indexed citations
8.
Milikovsky, Dan Z., Itai Weissberg, Lyna Kamintsky, et al.. (2017). Electrocorticographic Dynamics as a Novel Biomarker in Five Models of Epileptogenesis. Journal of Neuroscience. 37(17). 4450–4461. 48 indexed citations
9.
Milikovsky, Dan Z., Itai Weissberg, Lyna Kamintsky, et al.. (2017). Theta rhythm alterations – a novel predictive biomarker of epilepsy. Journal of the Neurological Sciences. 381. 86–86. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026